Comparative Pharmacology
Head-to-head clinical analysis: M V I ADULT PHARMACY BULK PACKAGE versus MULTIFUGE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: M V I ADULT PHARMACY BULK PACKAGE versus MULTIFUGE.
M.V.I. ADULT (PHARMACY BULK PACKAGE) vs MULTIFUGE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
M.V.I. Adult is a multivitamin formulation providing essential vitamins that serve as cofactors in various enzymatic reactions and metabolic pathways. Vitamin A is essential for vision and cell differentiation; B vitamins (B1, B2, B3, B5, B6, B7, B9, B12) act as coenzymes in energy metabolism, red blood cell production, and nerve function; Vitamin C is an antioxidant and cofactor for collagen synthesis; Vitamin D regulates calcium homeostasis; Vitamin E is an antioxidant; and Vitamin K is required for hepatic synthesis of clotting factors.
Multifuge is a combination product containing an antihistamine and a decongestant. The antihistamine (chlorpheniramine) competitively antagonizes histamine H1 receptors, reducing allergic symptoms. The decongestant (pseudoephedrine) stimulates alpha-adrenergic receptors, causing vasoconstriction and reducing nasal congestion.
10 mL intravenously once daily, added to 500 mL of compatible infusion fluid and administered over 8-24 hours.
IV: 10 mg/kg body weight as a single dose; repeated every 48 hours as needed.
None Documented
None Documented
Variable; thiamine (B1) ~9-18 min; riboflavin (B2) ~66-84 min; pyridoxine (B6) ~15-20 days; ascorbic acid (C) ~16-20 days (in deficiency states) or ~10-14 days (normal); retinol (A) ~2-3 days; ergocalciferol (D2) ~19-48 hours; alpha-tocopherol (E) ~40-60 hours; phytonadione (K1) ~1-2 hours.
The terminal elimination half-life is 7-9 hours in adults with normal renal function. This may be prolonged (up to 20-30 hours) in patients with severe renal impairment (CrCl <30 mL/min), necessitating dose adjustment.
Renal excretion of water-soluble vitamins (B-complex, C); bile/fecal elimination of fat-soluble vitamins (A, D, E, K). Approximate percentages: Vitamins B1, B2, B6, C: >90% renal; Vitamin A: 70% fecal, 30% renal metabolites; Vitamin D: 75% fecal, 25% renal; Vitamin E: >60% fecal; Vitamin K: 50% fecal, 50% renal.
Renal excretion of unchanged drug accounts for 60-70% of the administered dose, with the remainder undergoing hepatic metabolism to inactive metabolites that are excreted renally. Fecal elimination is minimal (<5%).
Category C
Category C
Multivitamin
Multivitamin/Mineral Supplement